Overexpression of human immunodeficiency virus type 1 protease increases intracellular cleavage of Gag and reduces virus infectivity

Virology

Volumn 206, Issue 2, 1995, Pages 854-865

  Mattias Luukkonen, B G ^a   Fenyö, Eva Maria ^a   Schwartz, Stefan ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0028821437     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1995.1008     Document Type: Article

References (70)

1. Adachi, A., Gendelman, H. E., Koenig, S., Folks, T., Willey, R., Rabson, A., and Martin, M. A. (1986). Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59, 284-291.
2. Bryant, M., and Ratner, L. (1990). Myristoylation-dependent replication and assembly of human immunodeficiency virus 1. Proc. Natl. Acad. Sci. USA 87, 523-527.
3. Buonocore, L., and Rose, J. K. (1993). Blockade of human immunodeficiency virus type 1 production in CD4+ T cells by an intracellular CD4 expressed under control of the viral long terminal repeat. Proc. Natl. Acad. Sci. USA 90, 2695-2699.
4. Cochrane, A. W., Jones, K. S., Beidas, S., Dillon, P. J., Skalka, A. M., and Rosen, C. (1991), Identification and characterization of intragenic sequences which repress human immunodeficiency virus structural gene expression, j. Virol. 65, 5305-5313.
5. Darke, P. L., Jordan, S. P., Hall, D. L., Zugay, J. A., Shafer, J. A., and Kuo, L. C. (1994), Dissociation and association of the HIV-1 protease dimer subunits= Equilibria and rates. Biochemistry 33, 98-105.
6. Dayton, A. I., Terwilliger, E. F., Potz, J., Kowalski, M., Sodroski, J. G., and Haseltine, W. A. (1988). Cis-acting sequences responsive to the rev gene product of the human immunodeficiency virus, J. Acquir. Immune Deficiency Syndr. 1, 441-452.
7. Emerman, M., Vazeux, Ft., and Peden, K. (1989). The rev gene product of the human immunodeficiency virus affects envelope-specific RNA localization. Cell 57, 1155-1165.
8. Erickson-Vntanen, S., Manfredi, J., Viitanen, P., Tribe, D. E., Tritch, R., Hutchinson, C. A., Loeb, D. D., and Swanstrom, R. (1989). Cleavage of HIV-1 gag polyprotein synthesized in vitro= Sequential cleavage by the viral protease. AIDS Res. Hum. Retroviruses. 5, 577-591.
9. Facke, M., Janetzko, A, Shoeman, R. L, and KrAusslich, H.-G. (1993). A large deletion in the matrix domain of the human immunodeficiency virus gag gene redirects virus particle assembly from the plasma membrane to the endoplasmatic reticulum. J. Virol. 67, 4972-4980.
10. Felber, B. K., Hadzopoulou-Cladaras, M., Cladaras, C., Copeland, I., and Pavlakis, G. N. (1989). rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA. Proc. Natl. Acad. Sci USA 86, 1495-1499.
11. Fuepst, T., Earl, P. L., and Moss, B. (1987). Use of a hybrid vaccinia virus-T7 RNA polymerase system for expression of target genes. Mol. Cell. Biol. 7, 2538-2544.
12. Fuerst, T. R., Niles, E. G., Studies, F. W., and Moss, B. (1986). Eucaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Scl USA 83, 8122-8126.
13. Gelderblom, H. R. (1991). Assembly and morphology of HIV; Potential effect of structure on viral function. AIDS 5, 617-638.
14. Gheysen, D., Jacobs, E., de Foresta, P., Thiriart, C., Francotte, M., Thines, D., and De Wilde, M. (1989). Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected cells. Cell 59, 103-112.
15. Gonzalez, S. A., Affranchino, J. L., Gelderblom, H. R., and Burny, A. (1993). Assembly of the matrix protein of simian immunodeficiency virus into virus-like particles. Virology 194, 548-556.
16. Goobar-Larsson, L, Luukkonen, B. G. M., Unge, T., Schwartz, S., Utter, G., Strandberg, B., and Oberg, B. (1995). Enhancement of HIV-1 proteinase activity by HIV-1 reverse transcriptase. Virology 206, 387-394.
17. Gorman, C. M., Moffat, L. F., and Howard, B. H. (1982). Recombinant 'genomes which express chloramphenicol acetyl transferase in mammalian cells. Mol Cell. Biol. 2, 1044-1051.
18. Gowda, S. D., Stein, B. S., and Engleman, E. G. (1989). Identification of protein intermediates in the processing of the p55 HIV-1 gag precursor in cells infected with recombinant vaccinia viruses. J. BioI. Chem. 264, 8459-8462.
19. Graham, F. J., and Van der Eb, A. J. (1973). A new technique for the assay of infectivity of human adenovirus 5 DNA Virology 52, 456-460.
20. Hadzopoulou-Cladaras, M., Felber, B. K., Cladaras, C., Athanasso-poulos, A., Tse, A., and Pavlakis, G. N. (1989). The rev (trs/art) protein of human immunodeficiency virus type 1 affects viral mRNA and protein expression via a c/s-acting sequence in the env region. J. Virol. 63, 1265-1274.
21. HammarskjOld, M. L., Heimer, J., HammarskjOld, B., Sangwan, I., Albert, L., and Rekosh, D. (1989). Regulation of human immunodeficiency virus env expression by the rev gene product. J. Virol. 63, 1959-1966.
22. Hansen, J., Billich, S., Schulze, T., Sukrow, S., and Moelling, K. (1988). Partial purification and substrate analysis of bacterially expressed HIV protease by means of monoclonal antibody. EMBOJ. 7, 1785-1791.
23. Hinkula, J., Rosen, J., Sundqvist, V.-A., Stigbrand, T., and Wahren, B. Epitope mapping of HIV-1 gag region with monoclonal antibodies. Mol. Immunol. 27, 395-403.
24. Hughes, B. P., Booth, T. P., Belyaev, A. S., McIlroy, D., Jowett, J., and Roy, P. (1993). Morphogenic capabilities of human immunodeficiency virus type 1 gag and gag-pol proteins in insect cells. Virology 193, 242-255.
25. Karacostas, V., Nagashima, K., Gonda, M. A., and Moss, B. (1989). Human immunodeficiency virus-like particles produced by vaccinia virus expression vector. Proc. Natl. Acad. Sci. USA 86, 8964-8967.
26. Karacostas, V., Wolffe, E. J., Nagashima, K., Gonda, M. A., and Moss, B. (1993). Overexpression of the HIV-1 Gag-Pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles. Virology 193, 661-671.
27. Kennedy, I. M., Haddow, J. K., and Clements, J. B. (1990). Analysis of human papillomavirus type 16 late mRNA 3' processing signals in vitro and in vivo. J. Virol. 64, 1825-1829.
28. Kohl, N. E., Emini, E. A., Schleif, W. A., David, L. J., Heimbach, J. C., Dixon, R. A., Scolnick, E. M., and Sigal, I. S. (1988). Active human immunodeficiency virus protease is required for viral infectivity. Proc. Natl. Acad. Sci. USA 85, 4686-4690.
29. Krausslich, H.-G. (1991). Human immunodeficiency virus proteinase dimer as component of the viral polyprotein prevents particle assembly and vira! infectivity. Proc. Natl. Acad. Sci. USA 88, 3213-3217.
30. Krausslich, H.-G. (1992), Specific inhibitor of human immunodeficiency virus proteinase prevents the cytotoxic effects of a single-chain proteinase dimer and restores particle formation. J. Viroi. 66, 567-572.
31. Krausslich, H.-G., Ochsenbauer, C., Traenckner, A.-M., Mergener, K., Facke, M., Gelderblom, H. R., and Bosch, V. (1993), Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase. Virology 192, 605-617.
32. Krausslich, H.-G., and Wimmer, E. (1988). Viral proteinases. Annu. Rev. Biochem. 57, 701-754.
33. Le Grice, S. F. J., Ette, R., Mills, J., and Mous, J. (1989). Comparison of the human immunodeficiency virus type 1 and 2 proteases by hybrid gene construction and trans-complementation. J. Biol. Chem. 264, 14902-14908.
34. Loeb, D. D., Swanstrom, R., Everitt, L, Manchester, M., Stamper, S. E., and Hutchinson, C. A. (1989). Complete mutagenesis of the HIV-1 protease. Nature (London) 340, 397-400.
35. Maldarelli, F., Martin, M. A., and Strebel, K. (1991). Identification of posttranscriptionally active Inhibitory sequences in human immunodeficiency virus type 1 RNA: Novel level of gene regulation. J. Virol. 65, 5732-5743.
36. Malim, M. H., Bohnlein, S., Hauber, J., and Cullen, B. R. (1989a). Functional dissection of the HIV-1 rev trans-activator-derivation of a trans-dominant repressor of rev function. Cell 58, 205-214.
37. Malim, M. H., Hauber, J., Le, S., Maizel, J. V., and Cullen, B. R. (1989b). The HIV-1 rev transactivator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature (London) 338, 254-257.
38. Marasco, W. A., Haseltine, W. A., and Chen, S. Y. (1993). Design, intracellular expression, and activity of a human anti-human immunodeficiency virus type 1 gp 120 single-chain antibody. Proc. Natl. Acad. Sci. USA 90, 7889-7893.
39. Mergener, K., Facke, M., Welker, R., Brinkmann, V., Gelderblom, H. R., and Krausslich, H.-G. (1992). Analysis of HIV particle formation using transient expression of subviral constructs in mammalian cells. Virology 186, 25-39.
40. Nabel, G. J., Fox, B. A., Post, L, Thompson, C. B., and Woffendin, C. (1994). A molecular genetic intervention for AIDS -effects of a transdominant negative form of Rev. Hum. Gene Ther. 5, 79-92.
41. Nasioulas, G., Zolotukhin, A. S., Tabernero, C., Solomin, L, Cunningham, C. P., Pavlakis, G. N., and Felber, B. K. (1994). Elements distinct from the human immunodeficiency virus type 1 splice sites are responsible for the Rev dependence of the env mRNA. J. Virol. 68, 2986-2993.
42. Oroszlan, S., and Luftig, R. B. (1990). Retroviral proteinases, Curr. Top. Microbiol. Immunol. 157, 153-185.
43. Park, J., and Morrow, C. D. (1991). Overexpression of the gag-pol precursor from human immunodeficiency virus type 1 proviral genomes results in efficient proteolytic processing in the absence of virion production. J. Virol. 65, 5111-5117.
44. Park, J., and Morrow, C. D. (1993). Mutations in the protease gene of human immunodeficiency virus type 1 affect release and stability of virus particles. Virology 194, 843-850.
45. Ratner, L., Fisher, A., Jagodzinski, L. L., Liou, R. S., Mitsuya, H., Gallo, R. C., and Wong-Staal, F. (1987a). Complete nucleotide sequences of functional clones of the virus associated with the acquired immunodeficiency syndrome, HTLV-III/LAV. Hamatol. Bluttransfus. 31, 404-406.
46. Ratner, L, Fisher, A., Jagodzinski, L. L, Mitsuya, H., Liou, R. S., Gallo, R. C., and Wong-Staal, F. (1987b). Complete nucleotide sequences of functional clones of the AIDS virus. AIDS Bes. Hum. Retroviruses 3, 57-69.
47. Rivière, Y., Blank, V., Kourilsky, P., and Israel, A. (1991). Processing of the precursor of NF-kB by the HIV-1 protease during acute infection. Nature (London) 350, 625-626.
48. Rosen, C. A., Terwilliger, E., Dayton, A., Sodroski, J. G., and Haseltine, W. A. (1988). Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 85, 2071-2075.
49. Schwartz, S., Campbell, M., Nasioulas, G., Harrison, J., Felber, B. K., and Pavlakis, G. N. (1992a). Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Rev-independent gag expression. J. Virol. 66, 7176-7182.
50. Schwartz, S., Felber, B. K., Benko, D. M., Fenyo, E. M., and Pavlakis, G. N. (1990). Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1. J. Virol. 64, 2519-2529.
51. Schwartz, S., Felber, B. K., and Pavlakis, G. N. (1992b). Distinct RNA sequences in the gag region of HIV-1 decrease RNA stability and inhibit expression in the absence of Rev protein. J. Virol. 66, 180-159.
52. Seedorf, K., Krammer, G., Durts, M., Suhai, S., and Rowekamp, W. G. (1985), Human papillomavirus type 16 DNA sequence. Virology 145, 181-185.
53. Shoeman, R. L., HOner, B., Stoller, T. J., Kesselmeier, C., Miedel, M. C., Traub, P., and Graves, M. C. (1990). Human immunodeficiency virus type 1 protease cleaves the intermediate filament proteins vi-mentin, desmin, and glial fibrillary acidic protein. Proc. Natl. Acad. Sci. USA 87, 6336-6340.
54. Shoeman, R. L, Kesselmeier, C., Mothes, E., Honer, B., and Traub, P. (1991). Non-viral cellular substrates for human immunodeficiency virus type 1 protease. FEBS lett. 278, 199-203.
55. Skalka, A. M. (1989). Retroviral proteases: First glimpse at the anatomy of a processing machine. Cell 56, 911-913.
56. Smith, A. J., Cho, M.-I., HammarskjCld, M.-L, and Rekosh, D. (1990). Human immunodeficiency virus type 1 Pr55gag and Pr160gag-pol expressed from a simian virus 40 replacement vector are efficiently processed and assembled into viruslike particles. J. Virol. 64, 2743-2750.
57. Smith, A. J., Srinivasakumar, N., HammarskjCld, M.-L., and Rekosh, D. (1993), Requirements for incorporation of Prl60gag-pol from human immunodeficiency virus type 1 into virus-like particles. J. Virol. 67, 2266-2275.
58. Smythe, J. A., Sun, D., Thomson, M., Markham, P. D., Reitz, M. S., Gallo, R. C., and Lisziewicz, J. (1994). A Rev-inducible mutant gag gene stably transferred into T lymphocytes: An approach to cene therapy against human immunodeficiency virus type 1 infection. Proc. Natl. Acad. Sci. USA 91, 3657-3661.
59. Solomin, L., Felber, B. K., and Pavlakis, G. N. (1990). Different sites of interaction for Rev, Tev, and Rex proteins within the rev responsive element of human immunodeficiency virus type 1. J. Virol. 64, 6010-6017.
60. Steffy, K. R., and Wong-Staal, F. (1993). Transdominant inhibition of wild-type human immunodeficiency virus type 2 replication by an envelope deletion mutant. J. Virol. 67, 1854-1859.
61. Sundquist, V., Albert, J., Ohlsson, E., Hinkula, J., Fenyo, E. M., and Wahren, B. (1989). HIV-1 p24 antigenic variations in tissue culture of isolates with defined growth characteristics. J. Med. Virol. 29, 170-175.
62. Tomasselli, A. G., Howe, W. J., Hui, J. O., Sawyer, T. K., Reardon, I. M., DeCamp, D. L., Craik, C. S., and Heinrikson, R. L. (1991). Calcium-free calmodulin is a substrate of proteases from human immunodeficiency viruses 1 and 2. Prate ins 10, 1-9.
63. Tomasselli, A. G., Hui, J. O., Sawyer, T. K., Staples, D. J., Bannow, C. A., Reardon, I. M., Chaudhary, V. K., Fryling, C. M., Pastan, I., Fitzgerald, D. J., and Heinrikson, R. L. (1990). Proteases from human immunodeficiency virus and avian myeloblastosis virus show distinct specificities in hydrolysis of multidomain protein substrates. J. Virol. 64, 3157-3161.
64. Tritch, R. J., Cheng, Y.-S. E., Yin, F. H., and Erickson-Viitanen, S. (1991). Mutagenesis of protease cleavage sites in human immunodeficiency
65. Trono, D., Feinberg, M. B., and Baltimore, D. (1989). HIV-1 Gag mutants can dominantly interfere with the replication of the wild-type virus. Cell 59, 113-120.
66. Veronese, F. D., Copeland, T. D., Oroszlan, S., Gallo, R. C., and Sarn-gadharan, M. G. (1938). Biochemical and immunological analysis of human immunodeficiency virus gag gene products p 17 and p24. J. Virol. 62, 795-801.
67. von der Helm, K., Gürtler, L., Eberle, J., and Deinhardt, F. (1989). Inhibition of HIV replication in cell culture by the specific aspartic protease inhibitor pepstatin A. FEBS Lett. 247, 349-352.
68. Wallin, M., Deinum, J., Goobar, L., and Danielson, U. H. (1990). Proteolytic cleavage of microtubule-associated proteins by retroviral pro-teinases. J. Gen. Virol. 71, 1985-1991.
69. Weiss, R., Teich, N., Varmus, H., and Coffin, J., in "Molecular Biology of Tumor Viruses. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York., 1985.
70. Zhang, Z. Y., Poorman, R. A., Maggiora, L. L, Heinrikson, R. L., and Kezdy, F. J. (1991). Dissociative inhibition of dimeric enzymes, kinetic characterization of the inhibition of HIV-1 protease by its COOH-terminal tetrapeptide. J. Biol. Chem. 266, 15591-15594.